Novartis Institutes For Biomedical Research (Nibr)

NIBR takes a unique approach to pharmaceutical research. At the earliest stages, research priorities are determined by patient need and disease understanding. At NIBR, physician-scientists are breaking down the boundaries between research and clinical practice. They use Proof-of-Concept clinical trials (small-scale studies used to get an early read on a drug’s safety and effectiveness) to help us find and advance the most promising drug candidates. They believe they can better answer the demand for safer, more effective medicines by keeping our sights on both the science and the patient.